Cinchocaine: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{ | {{drugbox | ||
| | | IUPAC_name = 2-butoxy-''N''-(2-diethylaminoethyl) quinoline-4-carboxamide | ||
| | | image = | ||
| | | CAS_number = 85-79-0 | ||
| | | ATC_prefix = C05 | ||
| | | ATC_suffix = AD04 | ||
| | | ATC_supplemental = {{ATC|D04|AB02}} {{ATC|N01|BB06}} {{ATC|S01|HA06}} | ||
| | | PubChem = 3025 | ||
| | | DrugBank = APRD00915 | ||
| | | C = 20 | H = 29 | N = 3 | O = 2 | ||
| | | molecular_weight = 343.463 g/mol | ||
| | | bioavailability = | ||
| | | protein_bound = | ||
| | | metabolism = | ||
| elimination_half-life = | |||
| excretion = | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| pregnancy_US = <!-- A / B / C / D / X --> | |||
| pregnancy_category = | |||
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 --> | |||
| legal_UK = <!-- GSL / P / POM / CD --> | |||
| legal_US = <!-- OTC / Rx-only --> | |||
| legal_status = | |||
| routes_of_administration = | |||
}} | }} | ||
==Overview== | |||
'''Cinchocaine''' (or '''Dibucaine''') is an [[amide]] [[local anesthetic]]. It is the active ingredient in some topical hemorrhoid creams. | |||
It is also a component of the [[veterinary]] drug '''Somulose''', used for [[animal euthanasia|euthanasia]] of horses and cattle. | |||
==External links== | |||
* {{cite journal | author = Abdel-Ghani N, Youssef A, Awady M | title = Cinchocaine hydrochloride determination by atomic absorption spectrometry and spectrophotometry. | journal = Farmaco | volume = 60 | issue = 5 | pages = 419-24 | year = 2005 | id = PMID 15910814}} | |||
* {{cite journal | author = Souto-Padron T, Lima AP, de Oliveira Ribeiro R. | title = Effects of dibucaine on the endocytic/exocytic pathways in Trypanosoma cruzi. | journal = Parasitol Res | volume = | issue = | pages = | year = 2006 | id = PMID 16612626}} | |||
* {{cite journal | author = Nounou M, El-Khordagui L, Khalafallah N | title = Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles. | journal = Acta Pol Pharm | volume = 62 | issue = 5 | pages = 369-79 | year = | id = PMID 16459486}} | |||
{{Vasoprotectives}} | |||
{{Antipruritics}} | |||
{{local anesthetics}} | |||
[[Category:Local anesthetics]] | |||
{{WikiDoc Help Menu}} | |||
{{WS}} |
Revision as of 20:22, 26 June 2014
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C20H29N3O2 |
Molar mass | 343.463 g/mol |
Overview
Cinchocaine (or Dibucaine) is an amide local anesthetic. It is the active ingredient in some topical hemorrhoid creams.
It is also a component of the veterinary drug Somulose, used for euthanasia of horses and cattle.
External links
- Abdel-Ghani N, Youssef A, Awady M (2005). "Cinchocaine hydrochloride determination by atomic absorption spectrometry and spectrophotometry". Farmaco. 60 (5): 419–24. PMID 15910814.
- Souto-Padron T, Lima AP, de Oliveira Ribeiro R. (2006). "Effects of dibucaine on the endocytic/exocytic pathways in Trypanosoma cruzi". Parasitol Res. PMID 16612626.
- Nounou M, El-Khordagui L, Khalafallah N. "Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles". Acta Pol Pharm. 62 (5): 369–79. PMID 16459486.
Template:Vasoprotectives Template:Antipruritics
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- CS1 maint: Multiple names: authors list
- Local anesthetics